Adjunctive aripiprazole versus placebo for antipsychotic-induced hyperprolactinemia: meta-analysis of randomized controlled trials.
<h4>Objective</h4>To compare the safety and efficacy of adjunctive aripiprazole versus placebo for antipsychotic-induced hyperprolactinemia.<h4>Methods</h4><h4>Population</h4>adult patients presenting with antipsychotic-induced hyperprolactinemia diagnosed by prol...
Enregistré dans:
Auteurs principaux: | Xianbin Li, Yilang Tang, Chuanyue Wang |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Public Library of Science (PLoS)
2013
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/4cfa137a5aca45f79cbcbad31f0db9ab |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Adjunctive treatment with aripiprazole for risperidone-induced hyperprolactinemia
par: Ranjbar F, et autres
Publié: (2015) -
Efficacy, acceptability, and safety of adjunctive aripiprazole in treatment-resistant depression: a meta-analysis of randomized controlled trials
par: Luan SX, et autres
Publié: (2018) -
Adjunctive simvastatin treatment in schizophrenia patients; a double blind randomized and placebo controlled trial
par: Somaieh Ashrafi, et autres
Publié: (2022) -
Hyperprolactinemia during antipsychotics treatment increases the level of coagulation markers
par: Ishioka M, et autres
Publié: (2015) -
Antipsychotic treatments for the elderly: efficacy and safety of aripiprazole
par: Izchak Kohen, et autres
Publié: (2010)